| Toward positional cloning of Vgt1, a QTL controlling the transition from the vegetative to the reproductive phase in maize S Salvi, R Tuberosa, E Chiapparino, M Maccaferri, S Veillet, ... Plant molecular biology 48, 601-613, 2002 | 175 | 2002 |
| Quinoa extract enriched in 20‐hydroxyecdysone protects mice from diet‐induced obesity and modulates adipokines expression AS Foucault, V Mathé, R Lafont, P Even, W Dioh, S Veillet, D Tomé, ... Obesity 20 (2), 270-277, 2012 | 144 | 2012 |
| Quinoa extract enriched in 20-hydroxyecdysone affects energy homeostasis and intestinal fat absorption in mice fed a high-fat diet AS Foucault, P Even, R Lafont, W Dioh, S Veillet, D Tomé, JF Huneau, ... Physiology & behavior 128, 226-231, 2014 | 96 | 2014 |
| 20-Hydroxyecdysone, from plant extracts to clinical use: therapeutic potential for the treatment of neuromuscular, cardio-metabolic and respiratory diseases L Dinan, W Dioh, S Veillet, R Lafont Biomedicines 9 (5), 492, 2021 | 86 | 2021 |
| 20-Hydroxyecdysone activates the protective arm of the RAAS via the MAS receptor R Lafont, M Serova, B Didry-Barca, S Raynal, L Guibout, L Dinan, ... Journal of Molecular Endocrinology 68 (2), 77-87, 2022 | 38 | 2022 |
| Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study … W Dioh, M Chabane, C Tourette, A Azbekyan, C Morelot-Panzini, ... Trials 22, 1-5, 2021 | 33 | 2021 |
| Beyond AREDS Formulations, What Is Next for Intermediate Age‐Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti‐inflammatory … S Camelo, M Latil, S Veillet, PJ Dilda, R Lafont Oxidative Medicine and Cellular Longevity 2020 (1), 4984927, 2020 | 32 | 2020 |
| Developing new drugs that activate the protective arm of the renin–angiotensin system as a potential treatment for respiratory failure in COVID-19 patients M Latil, S Camelo, S Veillet, R Lafont, PJ Dilda Drug Discovery Today 26 (5), 1311-1318, 2021 | 28 | 2021 |
| Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo V Fontaine, E Monteiro, E Brazhnikova, L Lesage, C Balducci, L Guibout, ... PLoS One 11 (12), e0167793, 2016 | 27 | 2016 |
| Combined genetic analysis of partial blast resistance in an upland rice population and recurrent selection for line and hybrid values S Veillet, MC Filippi, A Gallais Theoretical and applied genetics 92 (6), 644-653, 1996 | 24 | 1996 |
| Method of selecting sunflower genotypes with high oleic acid content in seed oil A Berville, S Lacombe, S Veillet, C Granier, S Leger, P Jouve | 21 | 2005 |
| A Phase 1 study for safety and pharmacokinetics of BIO101 (20‐hydroxyecdysone) in healthy young and older adults W Dioh, C Tourette, S Del Signore, L Daudigny, P Dupont, C Balducci, ... Journal of cachexia, sarcopenia and muscle 14 (3), 1259-1273, 2023 | 18 | 2023 |
| A2E-induced inflammation and angiogenesis in RPE cells in vitro are modulated by PPAR-α,-β/δ,-γ, and RXR antagonists and by norbixin V Fontaine, M Fournié, E Monteiro, T Boumedine, C Balducci, L Guibout, ... Aging (Albany NY) 13 (18), 22040, 2021 | 16 | 2021 |
| Ecdysteroid metabolism in mammals: The fate of ingested 20-hydroxyecdysone in mice and rats L Dinan, C Balducci, L Guibout, AS Foucault, A Bakrim, S Kumpun, ... The Journal of Steroid Biochemistry and Molecular Biology 212, 105896, 2021 | 13 | 2021 |
| Nourrir les hommes: un dictionnaire P Alary, D Bazile, E De Bélizal, S Berland, I Besson, S Boulakia, ... Editions Atlande, 2009 | 13 | 2009 |
| Systemic administration of the di-apocarotenoid norbixin (BIO201) is neuroprotective, preserves photoreceptor function and inhibits A2E and lipofuscin accumulation in animal … V Fontaine, E Monteiro, M Fournié, E Brazhnikova, T Boumedine, C Vidal, ... Aging (Albany NY) 12 (7), 6151, 2020 | 11 | 2020 |
| 20-hydroxyecdysone extract of pharmaceutical quality, use and preparation thereof R Lafont, P Dilda, W Dioh, P Dupont, SD Signore, S Veillet Patent FR3065644 A 1, 2020 | 8 | 2020 |
| Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial SM Lobo, G Plantefève, G Nair, AJ Cavalcante, NF de Moraes, E Nunes, ... EClinicalMedicine 68, 2024 | 7 | 2024 |
| A comparison between virus-versus patients-centred therapeutic attempts to reduce COVID-19 mortality S Camelo, M Latil, S Agus, W Dioh, S Veillet, R Lafont, PJ Dilda Emerging microbes & infections 10 (1), 2256-2263, 2021 | 7 | 2021 |
| Use of phytoecdysones in the preparation of a composition for acting on the metabolic syndrome S Veillet, R Lafont US Patent 8,236,359, 2012 | 7 | 2012 |
Jose Alain SahelSorbonne Université/ University of Pittsburgh School of MedicineEmail verificata su inserm.fr